Mithra Pharmaceuticals SA

ENXTBR:MITRA 주식 보고서

시가총액: €14.9m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Mithra Pharmaceuticals 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Christophe Marechal

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기7.4yrs
CEO 소유권n/a
경영진 평균 재임 기간4.3yrs
이사회 평균 재임 기간2.6yrs

최근 관리 업데이트

Recent updates

Not Many Are Piling Into Mithra Pharmaceuticals SA (EBR:MITRA) Stock Yet As It Plummets 26%

Apr 06
Not Many Are Piling Into Mithra Pharmaceuticals SA (EBR:MITRA) Stock Yet As It Plummets 26%

Revenues Working Against Mithra Pharmaceuticals SA's (EBR:MITRA) Share Price Following 39% Dive

Feb 07
Revenues Working Against Mithra Pharmaceuticals SA's (EBR:MITRA) Share Price Following 39% Dive

Party Time: Brokers Just Made Major Increases To Their Mithra Pharmaceuticals SA (EBR:MITRA) Earnings Forecasts

Nov 09
Party Time: Brokers Just Made Major Increases To Their Mithra Pharmaceuticals SA (EBR:MITRA) Earnings Forecasts

These Analysts Just Made A Huge Downgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) EPS Forecasts

Oct 05
These Analysts Just Made A Huge Downgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) EPS Forecasts

Take Care Before Diving Into The Deep End On Mithra Pharmaceuticals SA (EBR:MITRA)

May 23
Take Care Before Diving Into The Deep End On Mithra Pharmaceuticals SA (EBR:MITRA)

Bullish: Analysts Just Made A Huge Upgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) Forecasts

Aug 11
Bullish: Analysts Just Made A Huge Upgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) Forecasts

Growth Investors: Industry Analysts Just Upgraded Their Mithra Pharmaceuticals SA (EBR:MITRA) Revenue Forecasts By 21%

Mar 13
Growth Investors: Industry Analysts Just Upgraded Their Mithra Pharmaceuticals SA (EBR:MITRA) Revenue Forecasts By 21%

Mithra Pharmaceuticals (EBR:MITRA) Is Making Moderate Use Of Debt

Dec 22
Mithra Pharmaceuticals (EBR:MITRA) Is Making Moderate Use Of Debt

Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

Nov 24
Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

Here's Why Mithra Pharmaceuticals (EBR:MITRA) Can Afford Some Debt

Jun 07
Here's Why Mithra Pharmaceuticals (EBR:MITRA) Can Afford Some Debt

When Will Mithra Pharmaceuticals SA (EBR:MITRA) Turn A Profit?

May 10
When Will Mithra Pharmaceuticals SA (EBR:MITRA) Turn A Profit?

Is Mithra Pharmaceuticals SA's (EBR:MITRA) Shareholder Ownership Skewed Towards Insiders?

Mar 18
Is Mithra Pharmaceuticals SA's (EBR:MITRA) Shareholder Ownership Skewed Towards Insiders?

We're Not So Sure You Should Rely on Mithra Pharmaceuticals' (EBR:MITRA) Statutory Earnings

Feb 16
We're Not So Sure You Should Rely on Mithra Pharmaceuticals' (EBR:MITRA) Statutory Earnings

Analysts Expect Breakeven For Mithra Pharmaceuticals SA (EBR:MITRA) Before Long

Jan 21
Analysts Expect Breakeven For Mithra Pharmaceuticals SA (EBR:MITRA) Before Long

Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

Nov 29
Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

CEO

Christophe Marechal

7.4yrs

테뉴어

Mr. Christophe Maréchal has been the Chief Financial Officer of Mithra Pharmaceuticals SA since February 23, 2017 and also serves as its Co-Chief Executive Officer since March 5, 2024. Mr. Maréchal serves...


리더십 팀

이름위치테뉴어보상소유권
Christophe Marechal
Co-CEO & CFO7.4yrs데이터 없음데이터 없음
Xavier Paoli
COO & Co-CEOless than a year데이터 없음데이터 없음
Graham Dixon
Chief Scientific Officer5yrs데이터 없음데이터 없음
Alex Sokolowski
Head of Investor Relationsno data데이터 없음데이터 없음
Fanny Rozenberg
Secretary of the Board & General Counselno data데이터 없음데이터 없음
Fanny Storms
Compliance Officerno data데이터 없음데이터 없음
Frederique Depraetere
Communication Directorno data데이터 없음데이터 없음
Catherine Lejeune
HR Directorno data데이터 없음데이터 없음
Jean-Manuel Fontaine
Chief Business Officer3.5yrs데이터 없음0.000040%
€ 6.0
Jean-Michel Foidart
President of the Scientific Advisory Board & Executive Directorno data€7.12k0.029%
€ 4.4k
Christophe Saillez
Head of Global Regulatory Affairsno data데이터 없음데이터 없음
Maud Jost
Head of Program & Project Managementno data데이터 없음데이터 없음

4.3yrs

평균 재임 기간

경험이 풍부한 관리: MITRA 의 관리팀은 경험 ( 4.2 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Jean-Michel Foidart
President of the Scientific Advisory Board & Executive Director7.8yrs€7.12k0.029%
€ 4.4k
Jacques Platieau
Independent & Non-Executive Director1.5yrs€25.00k데이터 없음
Valerie Gordenne
Non-Executive Director2.6yrs€20.00k0.042%
€ 6.3k

2.6yrs

평균 재임 기간

경험이 풍부한 이사회: MITRA 의 이사회경험(평균 재직 기간 2.5 년)으로 간주되지 않으므로 새 이사회가 필요합니다.